It is known that MetS is characterized by the inability of insulin to adequately suppress hepatic gluconeogenesis, leading to hyperglycaemia, hyperinsulinemia and eventually to T2D [4]. The gene discussed is INS; the disease is type 2 diabetes mellitus.